PDRN and salmon DNA skincare: hype vs. what studies show

What did @brendaa.chan actually say?

The creator credits her 46-year-old mother's skin to a PDRN serum, calling it "the next hyaluronic acid" that works to "rejuvenate, hydrate and give you a plump skin effect." The video frames this as a straightforward anti-aging routine anchored by one hero ingredient. That framing deserves a closer look, because PDRN is not just another hydrating molecule, and the comparison to hyaluronic acid flattens something more biologically interesting, and more complicated.

The routine itself includes a double-cleanse, a centella-based toner, the PDRN serum, and an eye cream described as a "skin barrier" product. None of those steps are egregious. The PDRN claim, though, is doing a lot of heavy lifting.

Does the science back this up?

Partially, yes, but the mechanism matters. PDRN stands for polydeoxyribonucleotide, a DNA-fragment compound derived from salmon sperm. In clinical medicine, it has been studied primarily as an injectable, not a topical. That distinction is not minor.

Injectable PDRN has a real evidence base. It activates adenosine A2A receptors, which promotes tissue repair and can reduce inflammation. A 2014 study by Graziani et al. in the Journal of Vascular Surgery confirmed its wound-healing properties in ischemic tissue. Dermatology studies, including work by Bae et al. (2020, Journal of Cosmetic Dermatology), found intradermal PDRN injections improved skin elasticity and hydration markers in aging skin.

Topical PDRN is a different story. The molecule is large and fragmented, and there is limited peer-reviewed evidence that it penetrates the stratum corneum in meaningful concentrations. Most topical studies are manufacturer-funded and small. Comparing it to hyaluronic acid, which has decades of topical and injectable data behind it, overstates what we actually know about the topical form.

What did they get wrong (or right)?

The "next hyaluronic acid" framing is where this video oversells. Hyaluronic acid has robust topical data across thousands of subjects. Topical PDRN does not. Calling it the next HA implies a comparable evidence base, which does not exist yet for the topical route.

That said, the creator is not completely off base. PDRN is genuinely interesting science. The injectable research is solid enough that South Korean dermatologists use it in clinical settings. The interest in topical versions is not invented hype, it reflects a real gap researchers are trying to close. The creator just skipped the part where the topical evidence is still catching up to the injectable evidence.

The double-cleanse recommendation is fine. Centella asiatica toners have decent anti-inflammatory data behind them (Lee et al., 2016, Annals of Dermatology). Nothing in the routine is harmful. The problem is the causal story: attributing one woman's skin to a single serum in a sponsored video is not evidence of anything.

What should you actually know?

If you are interested in PDRN, the honest version of this story is that the injectable form has a legitimate scientific track record for skin repair and hydration. The topical form is plausible in theory but under-studied in practice. Most published topical PDRN studies are short, small, and lack independent replication.

The comparison to hyaluronic acid also misses what makes HA work topically: it is a humectant that functions largely on the skin surface, pulling water into the outer layers. PDRN is proposed to work through receptor activation and DNA repair mechanisms, which require cellular penetration. Whether topical formulations achieve that penetration at useful concentrations is still an open question.

This video is also a paid partnership with Anua. That does not make the product fake, but it does mean the framing is shaped by a commercial relationship. A 46-year-old with good skin could have genetics, sun protection habits, diet, sleep, and a dozen other variables doing most of the work. One serum is almost never the answer.

• Look for independent, non-manufacturer-funded topical PDRN studies before assuming the injectable data transfers directly to a cream.
• If you are curious about PDRN for skin repair, the injectable route has more evidence, and that is a conversation for a licensed dermatologist, not a TikTok shop link.
• Centella and double-cleansing have real supporting data. Those parts of this routine are defensible.